| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/30/2013 | CN102895208A Coated tablet formulation and method |
| 01/30/2013 | CN102895207A Diclofenac sodium sustained-release tablet and preparation method thereof |
| 01/30/2013 | CN102895206A Rhizoma bletillae polysaccharide gastric-floating tablet and preparation method and application thereof |
| 01/30/2013 | CN102895205A Rapidly-dissolved azilsartan pharmaceutical preparation |
| 01/30/2013 | CN102895201A Valproate semisodium tablet and its preparation method |
| 01/30/2013 | CN102895196A Method for preparing microspheres through oil in nano-particle suspension-oil in oil-solid in oil |
| 01/30/2013 | CN102895195A Preparation method of 5-fluorouracil molecular surface imprinting microsphere |
| 01/30/2013 | CN102895193A Method for preparing microspheres through oil in nano-particle suspension-oil in oil-water in oil |
| 01/30/2013 | CN102895192A Method for producing microsphere through oil-in-nanoparticle suspension-water-in-oil mode |
| 01/30/2013 | CN102895191A Method for preparing microspheres in oil-in-nanosuspension and solid-in-oil mode |
| 01/30/2013 | CN102895188A Borneol-curcumin liposome and preparation method and application thereof |
| 01/30/2013 | CN102895183A Cabazitaxel for injection and preparation method thereof |
| 01/30/2013 | CN102895180A Parasitic disease resistant compound triclabendazole transdermal solution for cattle and sheep and preparation method thereof |
| 01/30/2013 | CN102895179A Argatroban formulation comprising an acid as solubilizer |
| 01/30/2013 | CN102895178A Strong solution-type moxifloxacin hydrochloride injection and preparation method thereof |
| 01/30/2013 | CN102895177A Metronidazole mucilage and preparation method thereof |
| 01/30/2013 | CN102895176A Method for preparing porous gel containing recombinant human endostatin |
| 01/30/2013 | CN102895175A Prulifloxacin oral solid composition and preparation method thereof |
| 01/30/2013 | CN102423490B Nano-hybrid of brufen and hydrotalcite-like and preparation method thereof |
| 01/30/2013 | CN102327615B Bone targeting vector and medicament |
| 01/30/2013 | CN102302455B Method for preparing microsphere preparation coated with hydrophilic medicaments |
| 01/30/2013 | CN102228696B Polyethylene glycol-polyvinyl alcohol copolymer-metaxalone prodrug and synthesis method thereof |
| 01/30/2013 | CN102228676B Heparolysate injection pharmaceutical composition |
| 01/30/2013 | CN102228441B Dexibuprofen sustained-release pellet and preparation method thereof |
| 01/30/2013 | CN102218150B Novel liver-targeting nanometer Fe3O4MRI (Magnetic Resonance Imaging) contrast medium and preparation method |
| 01/30/2013 | CN102178829B Method for detecting ingredients of Chinese medicinal compound suppository for haemorrhoids |
| 01/30/2013 | CN102172397B In vivo targeting of dendritic cells |
| 01/30/2013 | CN102119930B Olmesartan medoxomil tablets and preparation method thereof |
| 01/30/2013 | CN102085203B Ophthalmic preparation of levofloxacin and prednisolone acetate and preparation method thereof |
| 01/30/2013 | CN102085175B Ophthalmic gel and preparation method thereof |
| 01/30/2013 | CN102078596B Application of toad peptide antibiotics in preparing drugs for treating hemorrhoids |
| 01/30/2013 | CN102048679B Transdermal preparation containing silodosin, preparation method and medicinal application thereof |
| 01/30/2013 | CN102008450B Drug-cyclodextrin nanoparticles and preparation method thereof |
| 01/30/2013 | CN101954088B Preparation method of medicine-carrying nano particle provided with specific identification radical on surface |
| 01/30/2013 | CN101933922B Amino acid composition containing new antioxidant |
| 01/30/2013 | CN101912447B Rhizoma corydalis total alkaloids self-emulsifying drug delivery system and preparation method and application thereof |
| 01/30/2013 | CN101909592B External preparation for skin |
| 01/30/2013 | CN101897732B Chinese medicinal effervescence medicament and preparation method thereof |
| 01/30/2013 | CN101856336B Mecobalamin sustained-release tablet and preparation method thereof |
| 01/30/2013 | CN101849913B Method for preparing veterinary florfenicol lung targeting gelatin microsphere |
| 01/30/2013 | CN101765421B Vesicle useful for external preparation for skin, and external preparation for skin comprising the vesicle |
| 01/30/2013 | CN101721709B Calcium phosphate and amphiphilic polymer composite medicament-carrying nano-microsphere, preparation method and application |
| 01/30/2013 | CN101664392B Gentamycin sulfate tablets and preparation method thereof |
| 01/30/2013 | CN101559037B Binary solution type preparation for intravenous injection and intracerebral injection |
| 01/30/2013 | CN101258166B Antibody combining with STEAP-1 protein and deriving molecule thereof |
| 01/30/2013 | CN101229295B Bone regeneration pain-relieving plaster |
| 01/29/2013 | US8362091 Foamable vehicle and pharmaceutical compositions thereof |
| 01/29/2013 | US8362089 Aqueous composition for cosmetics and cosmetic including the same |
| 01/29/2013 | US8362088 Method and article of manufacture for encapsulating a homeopathic ingredient with a second ingredient |
| 01/29/2013 | US8362087 Veterinary aqueous injectable suspensions containing florfenicol |
| 01/29/2013 | US8362062 Pharmaceutical compositions with improved dissolution |
| 01/29/2013 | US8361496 Phospholipid gel compositions for drug delivery and methods of treating conditions using same |
| 01/29/2013 | US8361491 Mesoporous implants for administering substances and methods of producing implants |
| 01/29/2013 | US8361476 With a carrier peptide adjuvant that is able to strongly enhance the immune response to a specific co-administered antigen |
| 01/29/2013 | US8361443 Peptide-based compounds |
| 01/29/2013 | US8361442 Oxime conjugates and methods for their formation and use |
| 01/29/2013 | US8361273 Polyurethane elastomers |
| 01/29/2013 | US8361272 Polyurethane elastomers |
| 01/29/2013 | US8361022 Apparatus for transdermal delivery of parathyroid hormone agents |
| 01/29/2013 | CA2676919C Novel biomaterials for ocular drug delivery and a method for making and using same |
| 01/29/2013 | CA2668245C Improved laxative composition and method |
| 01/29/2013 | CA2591581C Gel composition and methods |
| 01/29/2013 | CA2586807C Topical nepafenac formulations |
| 01/29/2013 | CA2582174C 4-hydroxy tamoxifen gel formulations |
| 01/29/2013 | CA2578015C Crystalline maltitol powder less prone to consolidation and method for production thereof |
| 01/29/2013 | CA2528360C Anesthetic composition for topical administration comprising lidocaine, prilocaine and tetracaine |
| 01/29/2013 | CA2454050C Pharmaceutical formulae for thyroid hormones and procedures for obtaining them |
| 01/29/2013 | CA2450123C Biodegradable polyhydric alcohol esters |
| 01/29/2013 | CA2448665C Sustained-release analgesic compounds |
| 01/24/2013 | WO2013013172A1 Intravaginal devices for drug delivery |
| 01/24/2013 | WO2013013055A1 System for drug delivery and monitoring |
| 01/24/2013 | WO2013013038A2 Doping agents and polymeric compositions thereof for controlled drug delivery |
| 01/24/2013 | WO2013012961A2 Novel crosslinking reagents, macromolecules, therapeutic conjugates, and synthetic methods thereof |
| 01/24/2013 | WO2013012924A2 Engineered microbe-targeting molecules and uses thereof |
| 01/24/2013 | WO2013012891A1 Intraperitoneally-administered nanocarriers that release their therapeutic load based on the inflammatory environment of cancers |
| 01/24/2013 | WO2013012725A1 Wound healing compositions and associated methods |
| 01/24/2013 | WO2013012683A2 Gel vaccine delivery system for treating poultry |
| 01/24/2013 | WO2013012628A2 Immune-stimulating photoactive hybrid nanoparticles |
| 01/24/2013 | WO2013012397A1 Method for encapsulating living cells in a keratin-containing hydrogel |
| 01/24/2013 | WO2013012022A1 Stable protein-containing preparation containing argininamide or analogous compound thereof |
| 01/24/2013 | WO2013012000A1 Water-based plaster |
| 01/24/2013 | WO2013011935A1 Therapeutic agent for bone fracture, bone growth enhancer, or therapeutic or prophylactic agent for bone diseases, each comprising carbon dioxide as active ingredient |
| 01/24/2013 | WO2013011598A1 Liposome-containing preparation utilizing dissolution aid, and method for producing same |
| 01/24/2013 | WO2013011504A1 Materials and method for treating internal body cavities |
| 01/24/2013 | WO2013011477A1 Pharmaceutical invention of tapentadol |
| 01/24/2013 | WO2013010942A1 Composition and method for treating hpv |
| 01/24/2013 | WO2013010840A2 Long acting biologically active luteinizing hormone (lh) compound |
| 01/24/2013 | WO2013010238A1 Microparticle pharmaceutical compositions containing antiparasitics for prolonged subcutaneous therapy, use of the pharmaceutical compositions for producing a medicament, and method for treating parasitoses |
| 01/24/2013 | WO2013010210A1 Oral compositions comprising an antacid, an anaesthetic and an inorganic matrix comprising silicon dioxide and titanium dioxide |
| 01/24/2013 | WO2012166923A3 Drug loaded polymeric nanoparticles and methods of making and using same |
| 01/24/2013 | WO2012153071A3 Functionalized polysaccharides |
| 01/24/2013 | WO2012151252A3 Composition and method for treatment of diabetes |
| 01/24/2013 | WO2012149393A9 Tolerogenic synthetic nanocarriers for antigen-specific deletion of t effector cells |
| 01/24/2013 | WO2012142328A3 Polymer microsphere compositions for localized delivery of therapeutic agents |
| 01/24/2013 | WO2012135522A3 Process for manufacturing conjugates of improved homogeneity |
| 01/24/2013 | WO2012135025A3 Conjugated lipomers and uses thereof |
| 01/24/2013 | WO2012099805A3 Nanoparticle based immunological stimulation |
| 01/24/2013 | US20130023879 Method for augmenting, reducing, and repairing bone with thermoplastic materials (as amended) |
| 01/24/2013 | US20130023688 Phosphorus-containing compounds with polymeric chains, and methods of making and using the same |
| 01/24/2013 | US20130023509 Hyaluronic acid based copolymers |